Thrivent Financial For Lutherans Astrazeneca PLC Transaction History

Thrivent Financial For Lutherans

$50.8 Billion
Q3 2025

A detailed history of Thrivent Financial For Lutherans transactions in Astrazeneca PLC stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 20,365 shares of AZN stock, worth $1.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,365

Previous 19,890 2.39%

Holding current value

$1.82 Million

Previous $1.39 Million 12.46%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 04, 2025	BUY	$68.72 - $82.11 $32,642 - $39,002	475 Added 2.39%	20,365 $1.56 Million
Q2 2025 Aug 26, 2025	SELL	$64.87 - $75.0 $200,448 - $231,750	-3,090 Reduced 13.45%	19,890 $1.39 Million
Q1 2025 Aug 26, 2025	BUY	$65.37 - $77.96 $1.5 Million - $1.79 Million	22,980 New	22,980 $1.49 Million
Q4 2024 Feb 10, 2025	SELL	$63.2 - $79.58 $1.14 Million - $1.44 Million	-18,090 Reduced 40.69%	26,365 $1.71 Million
Q3 2024 Nov 07, 2024	SELL	$76.67 - $87.62 $102 Million - $116 Million	-1,328,350 Reduced 96.76%	44,455 $3.46 Million

Q2 2024 Aug 13, 2024	SELL	$66.81 - $80.83 $2.75 Million - $3.33 Million	-41,164 Reduced 2.91%	1,372,805 $107 Million
Q1 2024 May 14, 2024	BUY	$61.03 - $69.57 $23.3 Million - $26.6 Million	381,837 Added 36.99%	1,413,969 $95.8 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $23.2 Million - $25.9 Million	374,489 Added 56.94%	1,032,132 $69.5 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $203,888 - $225,424	-3,144 Reduced 0.48%	657,643 $44.5 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $100 Million - $108 Million	-1,430,071 Reduced 68.4%	660,787 $47.3 Million
Q1 2023 May 17, 2023	BUY	$63.15 - $71.6 $52.9 Million - $60 Million	837,645 Added 66.84%	2,090,858 $145 Million
Q4 2022 Feb 08, 2023	SELL	$54.21 - $70.44 $1.62 Million - $2.1 Million	-29,824 Reduced 2.32%	1,253,213 $85 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $118,181 - $302,586	2,229 Added 0.17%	1,283,037 $70.4 Million
Q2 2022 Aug 16, 2022	SELL	$59.26 - $71.14 $2.49 Million - $2.99 Million	-42,080 Reduced 3.18%	1,280,808 $84.6 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $73.7 Million - $88.8 Million	1,322,888 New	1,322,888 $87.8 Million
Q4 2017 Feb 14, 2018	SELL	$32.09 - $34.78 $17,585 - $19,059	-548 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $15,870 - $18,632	548	548 $18,000

Others Institutions Holding AZN

# of Institutions

1,544

Shares Held

503M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Astrazeneca PLC Transaction History